Dr Jaroslav Boublik initially trained as an endocrine receptor biologist and peptide chemist. In the early 1990s, Dr Boublik made a shift into nutritional medicine, initially with a focus on human hydration research, and later more broadly in nutritional supplement research and development. Most recently he has shifted focus again to two areas of therapeutics set to disrupt current medical practice – cannabinoids and probiotics. Dr Boublik sits on the board of several leading companies in the nutritional and complementary medicine industry.

Director & Chief Science Officer/Biome Australia Ltd

JAROSLAV BOUBLIK

Session:

CLINICAL PHARMACY UPDATE: The potential of probiotics for the management of paediatric asthma

When:

Saturday 21 March, 11:55pm-12:25pm

Proudly sponsored by:

SESSION SPONSORS

PROGRAM SPONSORS

MAJOR SPONSORS

PRINCIPAL SPONSORS

APP2022 SPONSORS

SESSION SPONSOR

PROGRAM SPONSOR

MAJOR SPONSOR

VIEW ALL

PRINCIPAL SPONSOR

APP2020 SPONSORS

SPONSOR AND TRADE

(c) 2021 APP Conference 2022. All Rights Reserved.

LATEST NEWS

#APP2022

Events Division

The Pharmacy Guild of Australia

Queensland Branch

FOLLOW US

07 3831 9246

SITE CREDITS

CONTACT US

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:

APP Sand 1

AA8730

APP OCEAN 3

2F7A81

APP OCEAN 2

347D83

GOLD

D3A94A

TEAL 

4AB9B7